• Focus News EU is an independent media based in Europe
  • providing the world's latest news, the definitive source for independent journalism from every corner of the globe.

Gilead to Charge Hundreds Per Vial for Remdesivir

Business Ethan 1weeks ago (06-29) 6Views 0Comments

US Border Patrol: Crash Killing 7 Resulted From Human Smuggling Attempt in Texas

U.S. Border Patrol officials said a crash in El Paso, Texas, left at least seven people dead, blaming human smugglers for the incident. “Human smuggling is not a victimless crime,” El Paso Sector Border Patrol Chief Patrol Gloria Chavez said in a statement about the incident on June 25. “This is a tragic loss for our El Paso Community.” Three of the victims were illegal immigrants, including one from Guatemala and two from Mexico, the Border Patrol said on Saturday. The other four victims were residents of El Paso, including the 18-year-old driver, according to officials. The incident started on Thursday morning at around 1:30 a.m. when a border sensor sent out an alert about a suspicious vehicle with several passengers, officials told the El Paso Times. The vehicle was…

Gilead to Charge Hundreds Per Vial for Remdesivir

A California-based company is charging hundreds of dollars per vial for a drug it created that’s shown promise against COVID-19.

Gilead Sciences announced Monday it will begin to charge for remdesivir in July, which it previously donated for free to the United States and other countries.

Gilead is charging $390 per dose, which would come to $2,340 per patient for a five-day course or $4,290 for a 10-day course.

The pricing decision was based on making sure developed countries could access remdesivir, Gilead CEO Daniel O’Day said in an open letter.

The company is using a two-tiered pricing system in America, charging the lower amount for the U.S. government but elevating the price per vial for private insurance companies.

“Because of the way the U.S. system is set up and the discounts that government healthcare programs expect, the price for U.S. private insurance companies, will be $520 per vial,” O’Day said.

Citing the results of a study conducted by the U.S. government that showed remdesivir quickened time to hospital discharge, Gilead said the drug could result in hospital savings of approximately $12,000 per patient.

The Department of Health and Human Services (HHS), which has been helping distribute vials of remdesivir donated earlier this year, will continue to manage allocation to hospitals until the end of September, Gilead said. After that period of time, HHS won’t manage allocation any longer.

Gilead to Charge Hundreds Per Vial for Remdesivir Rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in March 2020. (Gilead Sciences via AP)

The Trump administration said in a separate announcement Monday that HHS and Gilead came to an agreement that gives the U.S. government large supplies of remdesivir through September.

The department isn’t purchasing the vials.

“HHS is merely guaranteeing allocation of more than 500,000 doses to the U.S. market at a price that would be no greater to the hospitals than the WAC,” a senior HHS official told reporters in a phone call, referring to Gilead’s Wholesale Acquisition Price.

The final donated doses were being shipped on Monday.

The agreement guarantees HHS more than 500,000 treatment courses, including all of Gilead’s projected production for July and most of its production of August and September.

An average treatment course requires 6.25 vials, health officials said.

Hospitals will pay no more than $3,200 per course.

Based on the hospital burden for COVID-19, HHS has been allocating the drug to state and local health departments, which then distribute the drug to hospitals. In the new configuration, HHS plans to allocate the vials directly to hospitals in shipments done every two weeks.

“President Trump has struck an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19,” Health Secretary Alex Azar said in a statement.

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for COVID-19 and secure access to these options for the American people.”

Follow Zachary on Twitter: @zackstieber

Focus News: Gilead to Charge Hundreds Per Vial for Remdesivir

US to Ship Remdesivir to States With Rising COVID-19 Cases

NEW YORK—The U.S. government will ship more of Gilead Sciences Inc’s antiviral treatment remdesivir to states experiencing an increase in COVID-19 cases including California, Texas, Florida, and Arizona, according to the Department of Health and Human Services’ (HHS) website. The government reallocated remdesivir to states with increasing cases, White House task force coordinator Deborah Birx said during a briefing on Friday. The HHS said on its website that the doses will ship starting Monday and extinguish the full amount of Gilead’s donation of 120,647 treatment courses. It said it would continue to work with Gilead to determine how the company’s anticipated inventory of 2 million doses by year’s end will be allocated. California will receive 464 cases of 40 vials each, Texas will receive 448 cases of 40 vials, Florida…


The article is from the Internet, and the content does not represent the position of this website.丨This website usesBY-NC-SAagreement for authorization
please indicate the link for reprint:Gilead to Charge Hundreds Per Vial for Remdesivir
Likes (0)
Post my comment
Cancel comment

Hi,You need to fill in your nickname and email address!

  • Nickname (Required)
  • Email (Required)
  • Link